• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Developing biomarker combinations in multicenter studies via direct maximization and penalization.通过直接最大化和惩罚在多中心研究中开发生物标志物组合。
Stat Med. 2020 Oct 30;39(24):3412-3426. doi: 10.1002/sim.8673. Epub 2020 Aug 13.
2
Biomarker combinations for diagnosis and prognosis in multicenter studies: Principles and methods.生物标志物组合在多中心研究中的诊断和预后:原则和方法。
Stat Methods Med Res. 2019 Apr;28(4):969-985. doi: 10.1177/0962280217740392. Epub 2017 Nov 20.
3
ROC analysis in biomarker combination with covariate adjustment.联合协变量调整的生物标志物 ROC 分析。
Acad Radiol. 2013 Jul;20(7):874-82. doi: 10.1016/j.acra.2013.03.009.
4
Combining biomarkers for classification with covariate adjustment.结合生物标志物进行分类并进行协变量调整。
Stat Med. 2017 Jul 10;36(15):2347-2362. doi: 10.1002/sim.7274. Epub 2017 Mar 9.
5
Combining biomarkers by maximizing the true positive rate for a fixed false positive rate.通过最大化固定假阳性率下的真阳性率来组合生物标志物。
Biom J. 2021 Aug;63(6):1223-1240. doi: 10.1002/bimj.202000210. Epub 2021 Apr 19.
6
Bayesian modeling and inference for diagnostic accuracy and probability of disease based on multiple diagnostic biomarkers with and without a perfect reference standard.基于有无完美参考标准的多种诊断生物标志物的疾病诊断准确性和概率的贝叶斯建模与推断。
Stat Med. 2016 Mar 15;35(6):859-76. doi: 10.1002/sim.6745. Epub 2015 Sep 28.
7
Average area under the curve: An alternative method for quantifying the dental caries experience in longitudinal studies.平均曲线下面积:一种用于量化纵向研究中龋齿发生情况的替代方法。
Community Dent Oral Epidemiol. 2019 Oct;47(5):441-447. doi: 10.1111/cdoe.12482. Epub 2019 Jun 26.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Robust estimation of area under ROC curve using auxiliary variables in the presence of missing biomarker values.在存在生物标志物值缺失的情况下使用辅助变量对ROC曲线下面积进行稳健估计。
Biometrics. 2011 Jun;67(2):559-67. doi: 10.1111/j.1541-0420.2010.01487.x. Epub 2010 Sep 3.
10
A boosting method for maximizing the partial area under the ROC curve.最大化 ROC 曲线下偏面积的一种提升方法。
BMC Bioinformatics. 2010 Jun 10;11:314. doi: 10.1186/1471-2105-11-314.

本文引用的文献

1
Biomarker combinations for diagnosis and prognosis in multicenter studies: Principles and methods.生物标志物组合在多中心研究中的诊断和预后:原则和方法。
Stat Methods Med Res. 2019 Apr;28(4):969-985. doi: 10.1177/0962280217740392. Epub 2017 Nov 20.
2
Standardized and weighted time-dependent receiver operating characteristic curves to evaluate the intrinsic prognostic capacities of a marker by taking into account confounding factors.标准化和加权时依接收器操作特性曲线,通过考虑混杂因素来评估标志物的内在预后能力。
Stat Methods Med Res. 2018 Nov;27(11):3397-3410. doi: 10.1177/0962280217702416. Epub 2017 Jun 20.
3
Combining biomarkers linearly and nonlinearly for classification using the area under the ROC curve.使用ROC曲线下面积将生物标志物进行线性和非线性组合以用于分类。
Stat Med. 2016 Sep 20;35(21):3792-809. doi: 10.1002/sim.6956. Epub 2016 Apr 5.
4
RiGoR: reporting guidelines to address common sources of bias in risk model development.RiGoR:解决风险模型开发中常见偏倚来源的报告指南。
Biomark Res. 2015 Jan 24;3(1):2. doi: 10.1186/s40364-014-0027-7. eCollection 2015.
5
Accounting for centre-effects in multicentre trials with a binary outcome - when, why, and how?在二分类结局的多中心试验中如何考虑中心效应——何时、为何以及如何?
BMC Med Res Methodol. 2014 Feb 10;14:20. doi: 10.1186/1471-2288-14-20.
6
ROC analysis in biomarker combination with covariate adjustment.联合协变量调整的生物标志物 ROC 分析。
Acad Radiol. 2013 Jul;20(7):874-82. doi: 10.1016/j.acra.2013.03.009.
7
Internal validation of risk models in clustered data: a comparison of bootstrap schemes.在聚类数据中对风险模型进行内部验证:引导方案的比较。
Am J Epidemiol. 2013 Jun 1;177(11):1209-17. doi: 10.1093/aje/kws396. Epub 2013 May 9.
8
Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve.使用协变量调整后的受试者工作特征曲线来调整协变量对分类准确性的影响。
Biometrika. 2009 Jun;96(2):371-382. doi: 10.1093/biomet/asp002. Epub 2009 Apr 1.
9
Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.使用肾单位损伤的尿生物标志物进行急诊科的诊断和预后分层:一项多中心前瞻性队列研究。
J Am Coll Cardiol. 2012 Jan 17;59(3):246-55. doi: 10.1016/j.jacc.2011.10.854.
10
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery.术后生物标志物可预测成人心脏手术后的急性肾损伤和不良结局。
J Am Soc Nephrol. 2011 Sep;22(9):1748-57. doi: 10.1681/ASN.2010121302. Epub 2011 Aug 11.

通过直接最大化和惩罚在多中心研究中开发生物标志物组合。

Developing biomarker combinations in multicenter studies via direct maximization and penalization.

作者信息

Meisner Allison, Parikh Chirag R, Kerr Kathleen F

机构信息

Department of Biostatistics, Johns Hopkins University, Baltimore, Maryland, USA.

Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA.

出版信息

Stat Med. 2020 Oct 30;39(24):3412-3426. doi: 10.1002/sim.8673. Epub 2020 Aug 13.

DOI:10.1002/sim.8673
PMID:32794249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10556091/
Abstract

Motivated by a study of acute kidney injury, we consider the setting of biomarker studies involving patients at multiple centers where the goal is to develop a biomarker combination for diagnosis, prognosis, or screening. As biomarker studies become larger, this type of data structure will be encountered more frequently. In the presence of multiple centers, one way to assess the predictive capacity of a given combination is to consider the center-adjusted area under the receiver operating characteristic curve (aAUC), a summary of the ability of the combination to discriminate between cases and controls in each center. Rather than using a general method, such as logistic regression, to construct the biomarker combination, we propose directly maximizing the aAUC. Furthermore, it may be desirable to have a biomarker combination with similar performance across centers. To that end, we allow for penalization of the variability in the center-specific AUCs. We demonstrate desirable asymptotic properties of the resulting combinations. Simulations provide small-sample evidence that maximizing the aAUC can lead to combinations with improved performance. We also use simulated data to illustrate the utility of constructing combinations by maximizing the aAUC while penalizing variability. Finally, we apply these methods to data from the study of acute kidney injury.

摘要

受一项关于急性肾损伤研究的启发,我们考虑生物标志物研究的情形,该研究涉及多个中心的患者,目标是开发用于诊断、预后或筛查的生物标志物组合。随着生物标志物研究规模的扩大,这种数据结构会更频繁地出现。在存在多个中心的情况下,评估给定组合预测能力的一种方法是考虑中心调整后的受试者工作特征曲线下面积(aAUC),它总结了该组合在每个中心区分病例和对照的能力。我们不是使用诸如逻辑回归等通用方法来构建生物标志物组合,而是建议直接最大化aAUC。此外,可能希望有一个在各中心具有相似性能的生物标志物组合。为此,我们允许对各中心特定AUC的变异性进行惩罚。我们证明了所得组合具有理想的渐近性质。模拟提供了小样本证据,表明最大化aAUC可以得到性能更优的组合。我们还使用模拟数据来说明在惩罚变异性的同时通过最大化aAUC构建组合的效用。最后,我们将这些方法应用于急性肾损伤研究的数据。